Haystack MRD™ by Quest Diagnostics is a tumor-informed, next-generation minimal residual disease (MRD) test that detects ultralow levels of circulating tumor DNA (ctDNA) to uncover residual disease after cancer treatment. Based on more than 20 years of clinical development and technology from pioneers in cancer genomics at Johns Hopkins University, Haystack MRD's purpose-built, high-precision science delivers novel insights that can help inform treatment decision-making.
Company Details
- Employees
- 54
- Founded
- -
- Address
- 301 W 29th St, Suite 2004u,germany
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.haystackmrd.com
- Keywords
- 3.
- HQ
- Baltimore, Maryland
Haystack Mrd™ By Quest Diagnostics® Questions
Haystack Mrd™ By Quest Diagnostics®'s website is http://www.haystackmrd.com
Haystack Mrd™ By Quest Diagnostics®'s LinkedIn profile is https://www.linkedin.com/company/haystack-oncology
Haystack Mrd™ By Quest Diagnostics® has
54 employees.
View email and phone details for 54
employees at Haystack Mrd™ By Quest Diagnostics®.
Haystack Mrd™ By Quest Diagnostics®'s industry is
Biotechnology Research
Haystack Mrd™ By Quest Diagnostics®'s top competitors are
Genedx,
Exact Sciences,
Quest Diagnostics Oncology,
Quest Diagnostics,
Natera,
Foresight Diagnostics,
Delfi Diagnostics,
Labcorp,
Guardant Health,
Freenome.
Haystack Mrd™ By Quest Diagnostics®'s categories are Biotechnology Research
Haystack Mrd™ By Quest Diagnostics®'s founding year is 2021
